Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Justera Health Ltd C.VTAL

Alternate Symbol(s):  SCRSF

Justera Health Ltd. is a Canadian company focused on health and wellness. It offers personalized healthcare services and solutions, such as IV Vitamin Therapy, premium nutritional supplements through its Naturevan Nutrition brand, a full 360-degree wellness and spa experience through Juillet Wellness that provides registered massage therapy, acupuncture, and new retail stores in Vancouver. Its... see more

CSE:VTAL - Post Discussion

Justera Health Ltd > Testing Numbers
View:
Post by Smokey1958 on May 10, 2022 9:49am

Testing Numbers

These testing numbers are trending as high or higher than the significant numbers alluded to back in ScreenPro's first quarter as a public company. Furthermore rather than the "approximations" posed by the first CEO these numbers are EXACT down to the last test.

Lena continues to act and deliver as the transparent, no nonsense CEO investors expected and deserved. This certainly provides an opportunity for the sp to move significantly once the incessant manipulating is finally undermined by strong volumes, financials and more great news.

While Morningstar's Fair Value sp assessment has dropped the current sp is less than half what it should be valued at. The overvalued and overbought territory is still nearing $.65. Hopefully a reversal in overall market sentiment will be reflected here as well.

GLTE!!!

Comment by mutjwo on May 10, 2022 10:22am
Agreed, This News Release really shows investors that Covid testing business remains strong and solid. 
Comment by bogdansz on May 12, 2022 7:39am
And add in to it that that new disease will show up in the future requiring testing
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities